RY

170.08

-0.3%↓

TD

94.41

+0.2%↑

BMO

130.02

+0.12%↑

BNS

73.7

-0.01%↓

CM

90.88

+0.25%↑

RY

170.08

-0.3%↓

TD

94.41

+0.2%↑

BMO

130.02

+0.12%↑

BNS

73.7

-0.01%↓

CM

90.88

+0.25%↑

RY

170.08

-0.3%↓

TD

94.41

+0.2%↑

BMO

130.02

+0.12%↑

BNS

73.7

-0.01%↓

CM

90.88

+0.25%↑

RY

170.08

-0.3%↓

TD

94.41

+0.2%↑

BMO

130.02

+0.12%↑

BNS

73.7

-0.01%↓

CM

90.88

+0.25%↑

RY

170.08

-0.3%↓

TD

94.41

+0.2%↑

BMO

130.02

+0.12%↑

BNS

73.7

-0.01%↓

CM

90.88

+0.25%↑

Search

Walker & Dunlop Inc

Atidarymo kaina

SektoriusFinansų sektorius

59.54 -0.32

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

59.09

Max

59.85

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-539K

33M

Pardavimai

41M

338M

P/E

Sektoriaus vid.

18.021

25.743

Dividendų pajamingumas

4.36

Pelno marža

9.661

Darbuotojai

1,399

EBITDA

-16M

106M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+39.65% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

4.36%

3.67%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-667M

2.1B

Ankstesnė atidarymo kaina

59.86

Ankstesnė uždarymo kaina

59.54

Naujienos nuotaikos

By Acuity

50%

50%

168 / 526 reitingas Finance

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Walker & Dunlop Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-31 22:20; UTC

Pagrindinės rinkos jėgos

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

2025-12-31 17:31; UTC

Pagrindinės rinkos jėgos

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

2025-12-31 16:30; UTC

Pagrindinės rinkos jėgos

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

2025-12-31 15:19; UTC

Pagrindinės rinkos jėgos

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

2025-12-31 15:17; UTC

Pagrindinės rinkos jėgos

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

2025-12-31 14:37; UTC

Pagrindinės rinkos jėgos

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

2026-01-01 23:35; UTC

Rinkos pokalbiai

Gold Rises Amid Geopolitical Risks -- Market Talk

2026-01-01 21:29; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

2026-01-01 21:29; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Sold Stake in JV to Tata Steel

2026-01-01 21:28; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

2026-01-01 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-01 09:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-31 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-31 21:13; UTC

Įsigijimai, susijungimai, perėmimai

10 People to Watch in Wealth Management in 2026 -- Barrons.com

2025-12-31 20:40; UTC

Rinkos pokalbiai

Dollar Posting Its Worst Year Since 2017 -- Market Talk

2025-12-31 20:22; UTC

Rinkos pokalbiai

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

2025-12-31 19:50; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

2025-12-31 19:31; UTC

Rinkos pokalbiai

Precious Metals Cap Off Record Runs -- Market Talk

2025-12-31 18:50; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-31 18:50; UTC

Rinkos pokalbiai

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

2025-12-31 17:17; UTC

Rinkos pokalbiai

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

2025-12-31 17:16; UTC

Pagrindinės rinkos jėgos

OwlTing Climbs on Launch of $10M Stock-Buyback Program

2025-12-31 17:15; UTC

Rinkos pokalbiai

Global Commodities Roundup: Market Talk

2025-12-31 17:00; UTC

Įsigijimai, susijungimai, perėmimai

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

2025-12-31 15:57; UTC

Įsigijimai, susijungimai, perėmimai

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

2025-12-31 15:54; UTC

Rinkos pokalbiai

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

2025-12-31 15:02; UTC

Pagrindinės rinkos jėgos

Nike Shares Rise After CEO Hill Buys $1M of Shares

2025-12-31 14:40; UTC

Įsigijimai, susijungimai, perėmimai

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

2025-12-31 14:20; UTC

Rinkos pokalbiai

Crude Futures On Track to End the Year With Losses -- Market Talk

2025-12-31 13:46; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Akcijų palyginimas

Kainos pokytis

Walker & Dunlop Inc Prognozė

Kainos tikslas

By TipRanks

39.65% į viršų

12 mėnesių prognozė

Vidutinis 84 USD  39.65%

Aukščiausias 95 USD

Žemiausias 75 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Walker & Dunlop Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

3

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

70.995 / 76.69Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

No Evidence

Rinkos nuotaikos

By Acuity

168 / 526 reitingas Finansų sektorius

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Walker & Dunlop Inc

Walker & Dunlop, Inc. is a holding company, which conducts its operations through Walker & Dunlop, LLC. The Company provides commercial real estate and financial services. It originates, sells, and services a range of commercial real estate debt and equity financing products and provides multifamily property sales brokerage and valuation services. It is also engaged in commercial real estate investment management activities. The Company provides housing market research and delivers real estate-related investment banking and advisory services. Through its agency products, the Company originates and sells loans pursuant to the programs of the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation and the Federal Housing Administration. Through its debt brokerage products, the Company brokers, and in some cases services, loans for various life insurance companies, commercial banks, commercial mortgage-backed securities issuers and other institutional investors.
help-icon Live chat